Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Anterix
ATEX
$1.94B
| $178K | ﹤0.01% |
4,487
-7,173
| -62% | -$232K |
|
3502
Karooooo
KARO
$2B
| $178K | ﹤0.01% |
6,062
-9,027
| -60% | -$259K |
|
3503
3D Systems Corp
DDD
$613M
| $177K | ﹤0.01% |
57,586
-69,435
| -55% | -$255K |
|
|
SEZL
3504
Sezzle
SEZL
$3.97B
| $177K | ﹤0.01% |
12,018
+4,818
| +67% | +$56.1K |
|
3505
Nano X Imaging
NNOX
$73.8M
| $176K | ﹤0.01% |
24,041
-14,768
| -38% | -$131K |
|
3506
Rackspace Technology
RXT
$1.24B
| $176K | ﹤0.01% |
59,101
-15,298
| -21% | -$30.7K |
|
|
PVBC
3507
DELISTED
Provident Bancorp
PVBC
| $176K | ﹤0.01% |
17,281
+690
| +4% | +$6.36K |
|
3508
Myers Industries
MYE
$1.29B
| $176K | ﹤0.01% |
13,118
-21,874
| -63% | -$398K |
|
3509
OneSpan
OSPN
$618M
| $175K | ﹤0.01% |
13,659
-20,717
| -60% | -$249K |
|
|
DADA
3510
DELISTED
Dada Nexus
DADA
| $175K | ﹤0.01% |
138,921
-579,636
| -81% | -$1.04M |
|
|
NXDR
3511
Nextdoor Holdings
NXDR
$986M
| $174K | ﹤0.01% |
62,761
-73,207
| -54% | -$169K |
|
|
WAY
3512
Waystar Holding Corp
WAY
$4.65B
| $174K | ﹤0.01% |
+8,100
| New | +$176K |
|
3513
Omeros
OMER
$959M
| $174K | ﹤0.01% |
42,767
-34,876
| -45% | -$125K |
|
3514
OrthoPediatrics
KIDS
$595M
| $174K | ﹤0.01% |
6,034
-10,029
| -62% | -$307K |
|
3515
Xometry
XMTR
$5.34B
| $173K | ﹤0.01% |
14,960
-16,551
| -53% | -$260K |
|
3516
Community Health Systems
CYH
$423M
| $173K | ﹤0.01% |
51,358
-64,833
| -56% | -$218K |
|
|
DHIL
3517
DELISTED
Diamond Hill
DHIL
| $172K | ﹤0.01% |
1,225
-1,418
| -54% | -$213K |
|
3518
Oak Valley Bancorp
OVLY
$281M
| $172K | ﹤0.01% |
6,897
-211
| -3% | -$5.04K |
|
|
HYZN
3519
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $172K | ﹤0.01% |
10,705
-1,217
| -10% | -$33.8K |
|
|
ALX
3520
Alexander's
ALX
$1.41B
| $172K | ﹤0.01% |
763
-1,900
| -71% | -$409K |
|
3521
Sagimet Biosciences
SGMT
$559M
| $171K | ﹤0.01% |
50,052
+33,710
| +206% | +$155K |
|
3522
IBEX
IBEX
$499M
| $171K | ﹤0.01% |
10,574
-3,702
| -26% | -$54.7K |
|
|
HLVX
3523
DELISTED
HilleVax
HLVX
| $171K | ﹤0.01% |
11,820
-60,450
| -84% | -$831K |
|
3524
Concrete Pumping Holdings
BBCP
$491M
| $170K | ﹤0.01% |
28,231
-13,751
| -33% | -$94.9K |
|
3525
Duluth Holdings
DLTH
$159M
| $169K | ﹤0.01% |
45,791
+11,091
| +32% | +$46.8K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.